Journal profile · Hematology
Journal of Clinical Apheresis
ISSN 0733-2459 · eISSN 1098-1101 · Wiley-Liss Inc. · UNITED STATES · Bimonthly · Founded 1982
Journal of Clinical Apheresis: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.79; hybrid open access; APC about USD 3,920; median 125 days to acceptance (100 articles, last 24 months); community-reported acceptance: fairly easy; 97 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Clinical Apheresis is published by Wiley-Liss Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Complement system in diseases, Hematopoietic Stem Cell Transplantation and Blood groups and transfusion, together about 33% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Clinical Apheresis publishes articles dealing with all aspects of hemapheresis. Articles welcomed for review include those reporting basic research and clinical applications of therapeutic plasma exchange, therapeutic cytapheresis, therapeutic absorption, blood component collection and transfusion, donor recruitment and safety, administration of hemapheresis centers, and innovative applications of hemapheresis technology. Experimental studies, clinical trials, case reports, and concise reviews will be welcomed. Effective with the 2016 volume, Journal of Clinical Apheresis, will be published in an online-only format.
From the journal's Aims & Scope
Research area (LetPub): Hematology
Editor-in-chief Jeffrey L. WintersPublisher website
Editorial board by country: none in mainland China; most named United States 9, Austria 2, United Kingdom 1, Germany 1 (13 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Complement system in diseasesImmunology and Microbiology15%
- Hematopoietic Stem Cell TransplantationMedicine10.3%
- Blood groups and transfusionMedicine7.7%
- Platelet Disorders and TreatmentsMedicine6.5%
- Blood transfusion and managementMedicine6.1%
- Hemoglobinopathies and Related DisordersMedicine6%
- Blood donation and transfusion practicesBusiness, Management and Accounting4.7%
- Renal Diseases and GlomerulopathiesMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCurrent ContentsPublisher website
Other: ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.79LetPub ·
- Impact factor (publisher)
- 2.8Publisher website ·
- Impact factor (publisher) 2025
- 2.8Publisher website ·
- CiteScore 2026-06
- 4.1LetPub ·
- CiteScore (publisher)
- 4.1Publisher website ·
- CiteScore (publisher) 2025
- 4.1Publisher website ·
- SJR 2026-06
- 0.89LetPub ·
- SNIP 2026-06
- 1.68LetPub ·
- h-index
- 43LetPub ·
- h-index
- 64OpenAlex ·
- i10-index
- 867OpenAlex ·
- 2-year mean citedness
- 0.89OpenAlex ·
- Self-citation rate
- 14.3%LetPub ·
- Share of gold OA articles
- 35.5%LetPub ·
Volume
- Articles per year
- 66LetPub ·
- Articles per year (publisher) 2025
- 77Publisher website ·
- Downloads per year (publisher) 2025
- 124,219Publisher website ·
Articles by year OpenAlex count · 2,509 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 103 | 57 | 13 |
| 2025 | 97 | 50 | 91 |
| 2024 | 62 | 40 | 128 |
| 2023 | 71 | 48 | 877 |
| 2022 | 82 | 30 | 460 |
| 2021 | 98 | 27 | 715 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
125 daysMedian, submission to acceptance · P25–P75 92 days – 170 days
- Acceptance to online
- median 14 days (101 articles)
- Submission to online
- median 139 days
- Sample
- 100 articles with submission and acceptance dates (197 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 41%Publisher website ·
- Acceptance rate (publisher) 2025
- 41%Publisher website ·
- Submission to first decision
- 38 daysPublisher website ·
- Submission to first decision 2025
- 38 daysPublisher website ·
- Submission to acceptance 2025
- 137 daysPublisher website ·
- Acceptance to publication 2025
- 13 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,920 / EUR 3,290 / GBP 2,560 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Reference style
- Author–date
- First submission
- Free format: the journal's layout is not required
Article types accepted9, with length limits
- apheresis illustratedIntroduction Article Types & Manuscript Preparation Research Articles Apheresis Illustrated Concise Reviews Brief Reports and Letters to the Editor Letters Edit…Length not stated
- brief reportBrief Reports: Short reports of cases, clinical experience, drug trials, or adverse effects may be submitted for editorial review. They may not exceed 750 words…main text ≤ 750 words · abstract ≤ 150 words
- brief reportsBrief Reports: Short reports of cases, clinical experience, drug trials, or adverse effects may be submitted for editorial review.Length not stated
- concise reviewsConcise Reviews The purpose of a "Concise Review" is to provide practicing physicians interested in the field and those in training with a clear and up-to-date …Length not stated
- editorialAll Manuscripts submitted to the Journal of Clinical Apheresis must be submitted solely to this journal, may not have been published in any part or form in anot…Length not stated
- lettersIntroduction Article Types & Manuscript Preparation Research Articles Apheresis Illustrated Concise Reviews Brief Reports and Letters to the Editor Letters Edit…Length not stated
- letters to the editorBrief Reports and Letters to the EditorLength not stated
- research articlesResearch ArticlesArticles welcomed for review include those reporting basic research and clinical applications of therapeutic plasma exchange, therapeutic cytap…Length not stated
- reviewResearch ArticlesArticles welcomed for review include those reporting basic research and clinical applications of therapeutic plasma exchange, therapeutic cytap…Length not stated
Policy excerpts from the journal's websitePublication ethics
- Publication ethics
Exclusive submission policy; manuscripts must not be published elsewhere and become the property of the publisher. Model summary
All Manuscripts submitted to the Journal of Clinical Apheresis must be submitted solely to this journal, may not have been published in any part or form in another publication of any type, professional or lay, and become the property of the publisher.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Liss Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1982
- ISSN
- 0733-2459
- Electronic ISSN
- 1098-1101
- Society / sponsor
- American Society for Apheresis
- Latest issue on the website
- Volume 41, Issue 5 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Journal of Clinical Apheresis
What CAS zone is Journal of Clinical Apheresis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Clinical Apheresis is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Clinical Apheresis?
The latest impact factor listed by LetPub is 2.79; CiteScore 4.1, h-index 64.
How long does peer review take at Journal of Clinical Apheresis?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 125 days (interquartile range 92–170 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 41% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Clinical Apheresis?
According to the journal's author guidelines: Reference style: Author–date; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Clinical Apheresis based?
Of the 13 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (9), Austria (2) and United Kingdom (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Clinical Apheresis?
According to LetPub and DOAJ records, Journal of Clinical Apheresis is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase and Current Contents; that list has not been checked against each database.
Is Journal of Clinical Apheresis open access, and what is the APC?
Journal of Clinical Apheresis is a hybrid journal. For open-access publication: APC about USD 3,920.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .